ClinVar Miner

Submissions for variant NM_024334.3(TMEM43):c.323T>C (p.Val108Ala)

gnomAD frequency: 0.00002  dbSNP: rs182351748
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 8
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Biesecker Lab/Clinical Genomics Section, National Institutes of Health RCV000172119 SCV000051058 uncertain significance not provided 2013-06-24 criteria provided, single submitter research
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine RCV000152048 SCV000200641 uncertain significance not specified 2015-03-12 criteria provided, single submitter clinical testing Variant classified as Uncertain Significance - Favor Benign. The p.Val108Ala var iant in TMEM43 has been identified in 1 Asian individual with HCM, who carried a pathogenic variant in a different HCM gene (LMM unpublished data). It has also been identified in 0.2% (19/8584) of East Asian chromosomes by the Exome Aggreg ation Consortium (ExAC, http://exac.broadinstitute.org; dbSNP rs182351748). Comp utational prediction tools and conservation analysis do not provide strong suppo rt for or against an impact to the protein. In summary, while the clinical signi ficance of the p.Val108Ala variant is uncertain, its frequency suggests that it is more likely to be benign.
GeneDx RCV000172119 SCV000236444 uncertain significance not provided 2019-08-14 criteria provided, single submitter clinical testing Reported in association with sudden arrhythmogenic death syndrome (SADS) and primary electric disease (PED) (Hata et al., 2016; Proost et al., 2017); Also reported in one individual from a cohort of individuals not selected for cardiomyopathy, arrhythmia, or family history of sudden cardiac death, who underwent exome sequencing (Ng et al., 2013); In silico analysis, which includes protein predictors and evolutionary conservation, supports a deleterious effect; This variant is associated with the following publications: (PMID: 23861362, 27005929, 28341588)
Color Diagnostics, LLC DBA Color Health RCV001176806 SCV001340863 likely benign Cardiomyopathy 2018-12-02 criteria provided, single submitter clinical testing
Invitae RCV001482753 SCV001687129 likely benign Arrhythmogenic right ventricular dysplasia 5 2023-11-15 criteria provided, single submitter clinical testing
Ambry Genetics RCV002444627 SCV002611782 benign Cardiovascular phenotype 2021-07-13 criteria provided, single submitter clinical testing This alteration is classified as benign based on a combination of the following: population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity.
Women's Health and Genetics/Laboratory Corporation of America, LabCorp RCV000152048 SCV002766458 likely benign not specified 2022-11-10 criteria provided, single submitter clinical testing
PreventionGenetics, part of Exact Sciences RCV003895044 SCV004715813 likely benign TMEM43-related condition 2022-05-04 criteria provided, single submitter clinical testing This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications).

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.